Examinando por Autor "Lista Paz, Ana"

Mostrando 1 - 4 de 4
  • Miniatura
    Ítem
    Aportaciones de la fisioterapia respiratoria como terapia adyuvante en pacientes con COVID-19 ingresados en UCI: una oportunidad de desarrollo
    (Academia de Ciencias Medicas de Bilbao, 2020-06) Franco Arizaga, Aitor Santi; Arbillaga Etxarri, Ane; Lista Paz, Ana; Martínez Ruiz, Alberto
  • Miniatura
    Ítem
    Fisioterapia respiratoria post-COVID-19: algoritmo de decisión terapéutica
    (Elsevier Espana S.L.U, 2022-01) Arbillaga Etxarri, Ane; Lista Paz, Ana; Alcaraz Serrano, Victoria; Escudero Romero, Raúl; Herrero Cortina, Beatriz; Balañá, Ana; Sebio, Raquel; Vilaró, Jordi; Gimeno Santos, Elena
    La pandemia causada por la enfermedad de la COVID-19 ha supuesto un gran reto para los profesionalesdel sistema sociosanitario, intensificándose con el manejo y atención de las manifestaciones clínicas quepotencialmente pueden presentarse de manera persistente en las personas que han superado la enferme-dad. Para ello, la fisioterapia respiratoria se presenta como piedra angular dentro del modelo de abordajeinterdisciplinar que requiere esta población. Dado que la implementación de esta opción terapéuticacontinúa siendo limitada en Espa˜na, es imprescindible realizar una evaluación integral y exhaustiva de lapersona que nos permita establecer criterios de selección a fin de optimizar el uso de los recursos huma-nos y materiales existentes. Para ello, se propone un algoritmo de decisión terapéutica basado en pruebasde evaluación validadas y objetivas de las posibles manifestaciones clínicas del paciente. La aplicación deeste algoritmo, en cualquier nivel asistencial (atención especializada y atención primaria/comunitaria)junto con la atención centrada en la persona, el impulso del uso de los espacios comunitarios verdes yazules de las ciudades y un adecuado uso de las tecnologías de la comunicación y la información, nospermitirá optimizar el modelo de atención de fisioterapia respiratoria en el contexto actual, marcado porla COVID-19.
  • No hay miniatura disponible
    Ítem
    Is non-invasive ventilation effective in improving the exercise capacity in patients with cardiac heart failure?: a randomised crossover trial
    (Public Library of Science, 2025-07-01) Mazzucco, Guillermo; Torres Castro, Rodrigo; Intelangelo, Leonardo; Lista Paz, Ana; Escalante, Juan Pablo; Zumeta Olaskoaga, Lore; Veiga, Gonzalo; Arbillaga Etxarri, Ane
    Introduction Heart failure (HF) is a prevalent global health issue, characterized by the heart’s inability to effectively pump or fill with blood, leading to inadequate cardiac output. Despite advances in medical treatments, exercise intolerance remains a significant challenge, impacting their quality of life and contributing to frequent hospitalizations. Recent studies suggest that non-invasive ventilation (NIV) may further enhance exercise performance by reducing ventilatory workload and fatigue. However, limited research has directly compared different ventilatory modes during exercise in patients with heart failure. This study aims to evaluate the effects of two NIV devices on exercise capacity. Methods A randomised crossover trial was conducted in patients with HF, reduced ejection fraction (≤ 40%), New York Heart Association functional class I-III and clinically stable. All participants underwent an initial assessment followed by an incremental exercise test to determine maximum aerobic velocity. They were then randomized to perform three constant work rate tests on separate days under three conditions: (1) with Continuous Positive Airway Pressure (CPAP), (2) with pressure support (PS) and (3) without NIV. The primary outcome was time to exhaustion. Key physiological variables were recorded during each test. Participants were recruited and completed all testing between April 29 and July 18, 2022. ClinicalTrials.gov registration number: NCT05433610. Results A total of 11 patients (mean age: 67±9.6 years) completed the study. Exercise duration was significantly longer in the pressure support group (9.8±6.2 minutes) compared to the CPAP group (8.9±6.0 minutes) and the control group (7.3±6.2 minutes) (p=0.043). No significant differences were found in average heart rate (HR), final HR, or oxygen saturation (SpO2) between the groups (p>0.05). Similarly, dyspnea and leg fatigue (modified Borg scale) showed no statistically significant differences between conditions (p>0.05). Conclusion The use of NIV, particularly the PS mode, during exercise significantly improved exercise duration in patients with HF compared to CPAP or no ventilatory support.
  • Miniatura
    Ítem
    Maximal respiratory pressure reference equations in healthy adults and cut-off points for defining respiratory muscle weakness
    (Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), 2023-12) Lista Paz, Ana; Langer, Daniel; Barral Fernández, Margarita; Quintela del Río, Alejandro; Gimeno Santos, Elena; Arbillaga Etxarri, Ane; Torres Castro, Rodrigo; Vilaró, Jordi; Varas de la Fuente, Ana B.; Serrano Veguillas, Cristina; Bravo Cortés, Pilar; Martín Cortijo, Concepción; García Delgado, Esther; Herrero Cortina, Beatriz; Valera, José Luis; Fregonezi, Guilherme A.F.; González Montañez, Carolina; Martín Valero, Rocío; Francín Gallego, Marina; Sanesteban Hermida, Yolanda; Giménez Moolhuyzen, Esther; Álvarez Rivas, Jorge; Ríos Cortés, Antonio Tomás; Souto-Camba, Sonia; González Doniz, Luz
    Introduction: Maximal inspiratory and expiratory pressures (PImax/PEmax) reference equations obtained in healthy people are needed to correctly interpret respiratory muscle strength. Currently, no clear cut-off points defining respiratory muscle weakness are available. We aimed to establish sex-specific reference equations for PImax/PEmax in a large sample of healthy adults and to objectively determine cut-off points for respiratory muscle weakness. Methods: A multicentre cross-sectional study was conducted across 14 Spanish centres. Healthy non-smoking volunteers aged 18–80 years stratified by sex and age were recruited. PImax/PEmax were assessed using uniform methodology according to international standards. Multiple linear regressions were used to obtain reference equations. Cut-off points for respiratory muscle weakness were established by using T-scores. Results: The final sample consisted of 610 subjects (314 females; 48 [standard deviation, SD: 17] years). Reference equations for PImax/PEmax included body mass index and a squared term of the age as independent variables for both sexes (p < 0.01). Cut-off points for respiratory muscle weakness based on T-scores ≥2.5 SD below the peak mean value achieved at a young age were: 62 and 83 cmH2O for PImax and 81 and 109 cmH2O for PEmax in females and males, respectively. Conclusion: These reference values, based on the largest dataset collected in a European population to date using uniform methodology, help identify cut-off points for respiratory muscle weakness in females and males. These data will help to better identify the presence of respiratory muscle weakness and to determine indications for interventions to improve respiratory muscle function.